EP Patent

EP3669866A1 — Pharmaceutical composition comprising apixaban

Assigned to KRKA dd · Expires 2020-06-24 · 6y expired

What this patent protects

The present invention relates to pharmaceutical compositions comprising apixaban, and to methods for preparing these pharmaceutical compositions. Furthermore, the present invention pertains to the use of pharmaceutical compositions comprising apixaban as a medicament.

USPTO Abstract

The present invention relates to pharmaceutical compositions comprising apixaban, and to methods for preparing these pharmaceutical compositions. Furthermore, the present invention pertains to the use of pharmaceutical compositions comprising apixaban as a medicament.

Drugs covered by this patent

Patent Metadata

Patent number
EP3669866A1
Jurisdiction
EP
Classification
—
Expires
2020-06-24
Drug substance claim
No
Drug product claim
No
Assignee
KRKA dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.